spacer
home > pmps > autumn 2018 > encounters in transportation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Encounters in Transportation

Supply chain logistics experts understand that the transportation of any type of goods comes with their own set of challenges. When cold chain logistics are taken into account, a new set of unique obstacles are introduced.

To start, the cold chain market is growing. According to Qy Research Groups’ Global Cold Chain Logistics Market Size, Status and Forecast 2022 report, the global cold chain market is expected to reach US $426.2 billion by 2022. Pharmaceutical Commerce reported that cold chain logistics spending is forecast to grow to more than US $16 billion by 2020. Data points back to the rising demand for pharmaceuticals as one of the main factors driving demand for the temperature-controlled supply chain. This demand also stems from an aging population, which, in turn, is starting to require more medication, which must stay at specified temperatures.

By 2050, 16% of the world’s population will be 65 or older. Baby Boomers started turning 65 in 2011, and the American Hospital Association projects that by 2030, more than 60% of this generation will be managing more than one chronic condition. Additionally, Milliman reports that increased life expectancies will trigger greater consumption patterns in the population for medical services and pharmaceuticals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Angela Kerr is Vice President of product portfolio at SpotSee. In this role, Angela focusses on building the company’s existing business and developing the next generation of cloud-based products that help customers costeffectively track their products around the globe. She has a Bachelor of Science degree in electrical engineering from Texas Tech University, US.
spacer
Angela Kerr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

New Temperature Profiles from a Global Study

Laminar Medica

Recently there has been an influx of temperature mapping studies to collect sufficient ambient data to develop temperature profiles.  Solid temperature profiles on specific shipping routes are required to ensure streamlined packaging and robust lane qualification. The most reliable method to develop temperature profiles is to capture the actual reading from shipments, as well as using the historical and meteorological data to increase the confidence level.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement